TransMedics Group, Inc. — Director's Dealing 2025

Feb 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2025-02-24

Reporting Person: Ranganath Anil P. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-24	Common Stock	A	5634	—	Acquired	14641	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-24	Stock Option (Right to Buy)	$77.12	A	8479	Acquired	2035-02-24	Common Stock (8479)	Direct

Footnotes

F1: Consists of 5,634 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: Includes 114 shares of Issuer's Common Stock acquired on December 31, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of July 1, 2024 to December 31, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2024.

F3: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.